Patent · US Active

Pyridons as PDK1 inhibitors

US8637549B2 · kind B2 · utility

2Cited by

0References

17Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Harald Engelhardt · Ebreichsdorf, AT
Guido Boehmelt · Ingelheim am Rhein, DE
Christiane Kofink · Perchtoldsdorf, AT
Daniel Kuhn · Düsseldorf, DE
Darryl McConnell · Wien, AT
Heinz Stadtmueller · Wien, AT

Key dates

Filing date	Jul 15, 2009
Grant date	Jan 28, 2014
Priority date	—
Expiry date	Jul 15, 2029

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D487/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention encompasses compounds of general formula (1) while the groups R4 to R7 and the units W, L, Qa and QH are defined as in claim 1, which are suitable for the treatment of diseases characterized by excessive or abnormal cell proliferation, and their use as medicaments having the above-mentioned properties.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.